propranolol has been researched along with sb 223412 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Batt, F; Blanc, S; Dutheuil, G; El Bousmaqui, M; Fraser, GL; Hoveyda, HR; Korac, J; Lapin, A; Lenoir, F; Noël, S; Roy, MO | 1 |
2 other study(ies) available for propranolol and sb 223412
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and optimization of novel antagonists to the human neurokinin-3 receptor for the treatment of sex-hormone disorders (Part I).
Topics: Androgens; Animals; Brain; Caco-2 Cells; Chemistry Techniques, Synthetic; CHO Cells; Cricetulus; Crystallography, X-Ray; Drug Discovery; Endocrine System Diseases; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; High-Throughput Screening Assays; Humans; Ligands; Luteinizing Hormone; Male; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Structure-Activity Relationship | 2015 |